News >

Immunotherapy Could Still Have Pivotal Role in Ovarian Cancer

Angelica Welch
Published: Tuesday, Sep 18, 2018

Matthew Powell, MD

Matthew Powell, MD

Although enthusiasm remains for developing immunotherapies for patients with ovarian cancer, phase II studies evaluating the treatment’s efficacy in the recurrent population have been disappointing thus far, explained Matthew Powell, MD.
... to read the full story
To Read the Full Story

View Conference Coverage
Online CME Activities
TitleExpiration DateCME Credits
Community Practice Connections™: 2nd Annual School of Nursing Oncology™Sep 28, 20191.5
Oncology Briefings™: A Nurses' Guide to Managing Adverse Events Associated with PARP InhibitorsJun 30, 20201.0
Publication Bottom Border
Border Publication